Chongqing Libang Pharmaceutical Development

Chongqing Libang Pharmaceutical Development is a specialized Chinese pharmaceutical company focused on the research, development, and large-scale manufacturing of complex injectable formulations and high-end generic drugs. The company is a recognized leader in the field of anesthesiology, particularly for its expertise in lipid emulsion technology used to produce critical sedative agents such as Propofol and Etomidate. Beyond its core anesthetic portfolio, Libang develops and manufactures treatments for cardiovascular conditions, hypertension, and clinical nutrition products. Operating from state-of-the-art GMP-certified facilities in Chongqing, the company serves both the domestic Chinese market and international clients through its contract manufacturing and API supply services. Libang is distinguished by its focus on targeted drug delivery systems and its commitment to maintaining international quality standards across its diverse product line.